Clinical Trial Tests AI Symptom Analysis via Pre-Visit Lab
ClinicalTrials.gov Studies
Summary
NIH registered a new experimental clinical trial (NCT07552311) titled 'Generative AI Plan for Care Lab Study' on April 27, 2026. The study will observe participants' interactions with generative AI models designed to respond to consumer symptom queries, providing information about possible urgency, potential causes or diagnoses, and a summary of information to bring to a healthcare visit. The trial involves Fitbit Plan for Care Lab and Baseline Model interventions targeting Primary Health Care conditions.
“This is an experimental study to observe participants' interactions with the Pre-visit Lab, and the output of various generative AI models that support consumer symptom queries and provide the user with information about possible urgency, potential causes or diagnoses based on the symptoms they disclose, and a summary of information to bring to a health care visit if planned.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
NIH registered a new clinical trial on ClinicalTrials.gov documenting an experimental study to observe how participants interact with generative AI models supporting consumer symptom queries. The AI systems being studied provide users with information about possible urgency of symptoms, potential causes or diagnoses based on disclosed symptoms, and summaries to bring to healthcare visits. The trial is classified under Primary Health Care conditions and involves Fitbit Plan for Care Lab and Baseline Model interventions.
For compliance and regulatory professionals, this trial represents an emerging area of AI deployment in healthcare consumer applications. Organizations developing or deploying similar generative AI tools for symptom assessment should consider how this research may inform future regulatory expectations around AI-based clinical decision support, particularly regarding urgency classification and diagnostic suggestions provided to non-clinical users.
Archived snapshot
Apr 28, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Generative AI Plan for Care Lab Study
N/A NCT07552311 Kind: NA Apr 27, 2026
Abstract
This is an experimental study to observe participants' interactions with the Pre-visit Lab, and the output of various generative AI models that support consumer symptom queries and provide the user with information about possible urgency, potential causes or diagnoses based on the symptoms they disclose, and a summary of information to bring to a health care visit if planned.
Conditions: Primary Health Care
Interventions: Fitbit Plan for Care Lab, Baseline Model
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.